Schulte-Mecklenbeck, Andreas 1985-
Andreas Schulte-Mecklenbeck researcher (ORCID 0000-0003-3855-4706)
VIAF ID: 4417148753693841320008 ( Personal )
Permalink: http://viaf.org/viaf/4417148753693841320008
Preferred Forms
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas | |
Cerebrospinal fluid concentrations of neuronal proteins are reduced in primary angiitis of the central nervous system | |
Classification of neurological diseases using multi-dimensional CSF analysis | |
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses | |
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients | |
Impaired NK-cell mediated regulation of T-cell activity in Multiple Sclerosis is reconstituted by therapeutic IL-2 receptor modulation | |
Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease A Case Series | |
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma | |
Intravenous methadone causes acute toxic and delayed inflammatory encephalopathy with persistent neurocognitive impairments | |
Single-cell profiling reveals preferential reduction of memory B cell subsets in cladribine patients that correlates with treatment response |